Vaxart, Inc. (VXRT) stock
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.15MP/E 3.2Yield –
Vaxart gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Vaxart's gross profit for the twelve months ending Jun 30, 2016 was -$25.20M, down 220.0% year over year. For fiscal 2015 it was $21.00M, up 19.3% from the year before. The highest annual figure on record is $21.00M in fiscal 2015.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | $21.00M | +19.3% |
| FY2014 | Jun 30, 2014 | $17.60M | +26.6% |
| FY2013 | Jun 30, 2013 | $13.90M | +32.4% |
| FY2012 | Jun 30, 2012 | $10.50M | +23.5% |
| FY2009 | Dec 26, 2009 | $8.50M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$6.80M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$5.20M | -572.7% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$6.50M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$6.70M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$20.00M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $1.10M | – |
See a number that looks wrong?